Get 40% Off
🚨 Volatile Markets? Find Hidden Gems for Serious Outperformance
Find Stocks Now

Microsoft, ServiceNow Partner To Boost Digital Transformation

Published 07/09/2019, 10:03 PM
Updated 07/09/2023, 06:31 AM

Microsoft (NASDAQ:MSFT) recently expanded partnership with ServiceNow (NYSE:NOW) with an aim to accelerate digital transformation. However, the financial terms of the deal have been kept under wraps.

With the partnership, Microsoft and ServiceNow are focusing on enhancing their portfolio with more intelligence and cognitive capabilities. This in turn will lead to incremental adoption of Now Platform, Microsoft 365 and Azure, benefiting the top line of both the companies.

Notably, ServiceNow, for the first time, will host its SaaS workloads on Azure, apart from its own private cloud platform. We believe that, this is a massive win for Azure.

Markedly, Microsoft has been partnering fellow enterprise software peers, including Oracle (NYSE:ORCL) , SAP and Adobe (NASDAQ:ADBE), to name a few, lately, to expand business opportunities.

Moreover, growing clout of Azure Infrastructure services is anticipated to challenge Amazon (NASDAQ:AMZN) Web Services, currently dominating cloud market with similar deal wins which include the likes of Okta and Splunk.



Microsoft’s strategic initiatives to broaden its market reach in Software-as-a-Service (SaaS) and cloud market are instilling confidence in the stock. Notably, shares of Microsoft have returned 35.9% in the past year, outperforming the industry’s rally of 29.9%.

Exploring the Facets of the Partnership

ServiceNow also selected Azure Cloud integrated with data security and compliance capabilities as “preferred cloud platform.” This is expected to enable ServiceNow to further penetrate highly regulated industries, and government and public sector markets.

ServiceNow will be made available in Azure Government in the United States and Azure Regions in Australia, with further roll out in the days ahead. Particularly, deployment of ServiceNow in Azure Government is anticipated to upscale the availability of Now Platform, leading to growth in U.S. government and federal agencies.

Moreover, this integration is expected to strengthen Azure Government service with ServiceNow’ digital workflows, consequently bolstering its adoption.

As part of the new agreement, Microsoft aims to deploy “IT & Employee Experience workflow” offerings from ServiceNow, which will be a separate transaction. This will enable the tech giant to improve automated operations, employee experience, and devise effective business decisions.

New Deal Revs Up Software Enterprise & Cloud Market

Higher integration of Microsoft’s enterprise software capabilities and Azure infrastructure services with ServiceNow’s digital workflow offerings is expected to bolster customer base of both the companies. This is expected to strengthen Microsoft and ServiceNow’s competitive position in the rapidly growing SaaS market, against common rival, salesforce.com (NYSE:CRM) .

Markedly, per Gartner, the global SaaS market is expected to hit $143.7 billion by 2022 compared with $80 billion valuation in 2018.

Moreover, per IDC data, global spending on public cloud services and related infrastructure is envisioned to hit $210 billion in 2019, up 23.8% over 2018. Microsoft’s initiative to strengthen Azure Government service with ServiceNow’s digital workflows reinforces its growth prospects in this domain.

With the transformed IT environment, increasing spending on cloud based applications and growing clout of digital transformation favor the growth prospects of the latest partnership.

Zacks Rank

Microsoft currently carries a Zacks Rank #3 (Hold). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

Breakout Biotech Stocks with Triple-Digit Profit Potential

The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.

Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +98%, +119% and +164% in as little as 1 month. The stocks in this report could perform even better.

See these 7 breakthrough stocks now>>

ServiceNow, Inc. (NOW): Free Stock Analysis Report

salesforce.com, inc. (CRM): Free Stock Analysis Report

Oracle Corporation (ORCL): Free Stock Analysis Report

Microsoft Corporation (MSFT): Free Stock Analysis Report

Original post

Zacks Investment Research

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.